Adline Chem Lab Ltd: Intrinsic Value & Share Price Analysis

Q: What is the current share price and 52-week range of Adline Chem Lab Ltd?

Adline Chem Lab Ltd is trading at 11.30 as of 03 May 2026, with a FY2026-2027 high of 19.1 and low of 7.60. The stock is currently in the middle of its 52-week range. Market cap stands at 6.60 Cr..

Q: Is Adline Chem Lab Ltd financially healthy?

Key indicators: ROCE of % is on the lower side. Dividend yield is 0.00 %.

Q: Is Adline Chem Lab Ltd profitable and how is the profit trend?

Adline Chem Lab Ltd reported a net profit of 0 Cr in Mar 2025. Compared to 1 Cr in Mar 2022, the net profit shows a declining trend.

Fair Value

₹74.05Undervalued by 555.31%vs CMP ₹11.30

P/E (220.0) × ROE (15.0%) × BV (₹2.75) × DY (2.00%)

Defaults: ROE=15%

₹18.86Undervalued by 66.90%vs CMP ₹11.30

MoS: +40.1% (Strong)Confidence: 38/100 (Low)Models: 1 Under, 2 Over

Model	Category	Value	Weight	Signal
PE-ROE	Earnings	₹39.03	47%	Under (+245.4%)
Graham Number	Earnings	₹1.76	35%	Over (-84.4%)
Earnings Yield	Earnings	₹0.50	19%	Over (-95.6%)
Consensus (3 models)		₹18.86	100%	Undervalued

Key Drivers: EPS CAGR -47.3% drags value — could be higher if earnings stabilize. | P/E of 220 makes PE-ROE unreliable — asset/earnings models are better benchmarks.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: -47.3% · Defaults: ROE=15%

*Investments are subject to market risks

Analyst Summary

Adline Chem Lab Ltd operates in the Pharmaceuticals segment, NSE: ADLINE | BSE: 524604, current market price is ₹11.30, market cap is 6.60 Cr.. At a glance, stock P/E is 220, ROE is %, ROCE is %, book value is 2.75, dividend yield is 0.00 %. The latest intrinsic value estimate is ₹18.86, which is about 66.9% above the current price, so the page currently reads as potentially undervalued rather than fully priced. On operating trend, latest reported sales are about ₹0 Cr, while latest net profit is about ₹0 Cr with a prior-period change of 51.9%. The 52-week range shown on this page is 19.1/7.60, which helps frame where the current quote sits within its recent trading band. Business context: About the Company - Qualitative AnalysisAdline Chem Lab Ltd. is a Public Limited Listed company incorporated on 06/07/1988 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L2423…

This summary is generated from the stock page data available for Adline Chem Lab Ltd: Intrinsic Value & Share Price Analysis and is refreshed automatically when the underlying metrics change.

Investment Snapshot

Adline Chem Lab Ltd scores 40/100 (Weak)

Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison

Stock Health18/100 · Weak

ROCE 0.0% WeakROE 0.0% WeakD/E 1.30 High debtInterest Coverage 0.0x RiskyProfitable 1/5 years Inconsistent

Smart Money35/100 · Weak

Promoter decreased by 3.76% Caution

Earnings Quality65/100 · Strong

OPM expanding (-20% → 0%) Improving

Quarterly Momentum50/100 · Moderate

Industry Rank30/100 · Weak

P/E 220.0 vs industry 59.5 Premium to peers3Y sales CAGR: -100% Shrinking

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 26, 2026, 12:41 am

Market Cap	6.60 Cr.
Current Price	11.3
Intrinsic Value	₹18.86
High / Low	19.1/7.60
Stock P/E	220
Book Value	2.75
Dividend Yield	0.00 %
ROCE	%
ROE	%
Face Value	10.0
PEG Ratio	-4.65

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Adline Chem Lab Ltd

Competitors

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Adline Chem Lab Ltd	6.60 Cr.	11.3	19.1/7.60	220	2.75	0.00 %	%	%	10.0
Concord Drugs Ltd	112 Cr.	85.0	92.5/29.0	211	26.1	0.00 %	4.73 %	0.88 %	10.0
Wockhardt Ltd	22,833 Cr.	1,405	1,870/1,087	210	281	0.00 %	3.75 %	1.22 %	5.00
Sequent Scientific Ltd	8,768 Cr.	201	260/111	203	32.2	0.00 %	8.47 %	3.21 %	2.00
Achyut Healthcare Ltd	128 Cr.	5.42	6.80/3.18	297	1.34	0.00 %	2.26 %	1.77 %	1.00
Industry Average	19,737.15 Cr	1,103.08		59.48	201.13	0.36%	16.35%	15.16%	6.10

All Competitor Stocks of Adline Chem Lab Ltd

Quarterly Result

Metric	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Expenses	0.41	0.08	0.08	0.03	0.00	0.07	0.10	0.07	0.10	0.06	0.03	0.05	0.03
Operating Profit	-0.41	-0.08	-0.08	-0.03	0.00	-0.07	-0.10	-0.07	-0.10	-0.06	-0.03	-0.05	-0.03
OPM %
Other Income	0.39	0.07	0.00	0.00	0.00	0.03	0.00	0.00	0.00	0.25	0.00	0.00	0.00
Interest	0.00	0.00	0.00	0.03	0.03	0.00	0.03	0.03	0.03	0.03	0.03	0.03	0.04
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit before tax	-0.02	-0.01	-0.08	-0.06	-0.03	-0.04	-0.13	-0.10	-0.13	0.16	-0.06	-0.08	-0.07
Tax %	0.00%	0.00%	0.00%	-16.67%	-33.33%	0.00%	-7.69%	-10.00%	-7.69%	-31.25%	-16.67%	-12.50%	-14.29%
Net Profit	-0.02	-0.01	-0.08	-0.05	-0.02	-0.04	-0.13	-0.09	-0.12	0.21	-0.05	-0.07	-0.06
EPS in Rs	-0.03	-0.02	-0.14	-0.09	-0.03	-0.07	-0.22	-0.15	-0.21	0.36	-0.09	-0.12	-0.10

Last Updated: March 3, 2026, 1:01 pm

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 26, 2026, 3:46 pm

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	13.45	15.36	16.94	17.18	8.10	5.59	6.59	6.33	0.74	0.00	0.00	0.00	0.00
Expenses	12.43	14.42	16.50	15.97	7.23	5.01	9.91	6.56	1.04	0.80	0.18	0.30	0.17
Operating Profit	1.02	0.94	0.44	1.21	0.87	0.58	-3.32	-0.23	-0.30	-0.80	-0.18	-0.30	-0.17
OPM %	7.58%	6.12%	2.60%	7.04%	10.74%	10.38%	-50.38%	-3.63%	-40.54%
Other Income	0.02	0.08	0.10	0.08	0.21	0.25	0.26	0.00	1.33	-3.35	0.00	0.25	0.25
Interest	0.57	0.48	0.44	0.32	0.34	0.07	0.02	0.03	0.01	0.00	0.12	0.16	0.13
Depreciation	0.46	0.51	0.09	0.96	0.73	0.73	0.42	1.02	0.35	0.09	0.00	0.00	0.00
Profit before tax	0.01	0.03	0.01	0.01	0.01	0.03	-3.50	-1.28	0.67	-4.24	-0.30	-0.21	-0.05
Tax %	0.00%	33.33%	100.00%	0.00%	100.00%	0.00%	7.43%	0.00%	-7.46%	0.00%	-10.00%	-33.33%
Net Profit	0.01	0.02	0.01	0.01	0.00	0.03	-3.76	-1.28	0.72	-4.23	-0.27	-0.13	0.03
EPS in Rs	0.02	0.03	0.02	0.02	0.00	0.05	-6.43	-2.19	1.23	-7.23	-0.46	-0.22	0.05
Dividend Payout %	0.00%	0.00%	0.00%	0.00%		0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	100.00%	-50.00%	0.00%	-100.00%	-12633.33%	65.96%	156.25%	-687.50%	93.62%	51.85%
Change in YoY Net Profit Growth (%)	0.00%	-150.00%	50.00%	-100.00%	-12533.33%	12699.29%	90.29%	-843.75%	781.12%	-41.77%

Adline Chem Lab Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	%

Compounded Profit Growth
10 Years:	%
5 Years:	14%
3 Years:	19%
TTM:	79%

Stock Price CAGR
10 Years:	%
5 Years:	29%
3 Years:	24%
1 Year:	-13%

Return on Equity
10 Years:	%
5 Years:	%
3 Years:	%
Last Year:	%

Last Updated: September 5, 2025, 2:06 pm

Balance Sheet

Last Updated: December 4, 2025, 2:18 am

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Sep 2025
Equity Capital	5.85	5.85	5.85	5.85	5.85	5.85	5.85	5.85	5.85	5.85	5.85	5.85	5.85
Reserves	1.21	1.21	1.21	1.19	1.18	1.18	-2.64	-3.92	-3.20	-7.42	-7.22	-7.34	-7.46
Borrowings	6.69	9.25	9.01	9.94	11.32	5.35	2.85	2.50	1.32	1.33	1.36	1.49	1.65
Other Liabilities	2.77	2.32	2.34	3.97	5.01	9.46	1.52	1.20	0.91	0.31	0.06	0.08	0.08
Total Liabilities	16.52	18.63	18.41	20.95	23.36	21.84	7.58	5.63	4.88	0.07	0.05	0.08	0.12
Fixed Assets	8.17	10.08	10.27	12.68	12.45	11.99	4.78	3.64	4.43	0.00	0.00	0.00	0.00
CWIP	0.20	0.20	0.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	8.15	8.35	7.94	8.27	10.91	9.85	2.80	1.99	0.45	0.07	0.05	0.08	0.12
Total Assets	16.52	18.63	18.41	20.95	23.36	21.84	7.58	5.63	4.88	0.07	0.05	0.08	0.12

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	1.31	0.39	0.83	2.46	0.89	-0.95	-11.34	-0.29	0.21	0.01	-0.17	-0.23
Cash from Investing Activity +	-1.04	-2.44	-0.21	-3.18	-0.37	-0.28	11.24	0.12	0.00	0.00	0.00	0.00
Cash from Financing Activity +	-0.09	2.18	-0.78	0.63	1.04	-0.29	-0.02	-0.03	-0.01	0.00	0.15	0.25
Net Cash Flow	0.18	0.12	-0.15	-0.09	1.56	-1.51	-0.12	-0.21	0.20	0.01	-0.02	0.02
Free Cash Flow	0.27	-2.06	0.62	-0.73	0.36	-1.23	-0.10	-0.17	0.21	0.01	-0.17	-0.23
CFO/OP	128%	41%	189%	203%	102%	-164%	342%	126%	-70%	-1%	94%	110%

Free Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	-5.67	-8.31	-8.57	-8.73	-10.45	-4.77	-6.17	-2.73	-1.62	-2.13	-1.54	-1.79

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Debtor Days	53.46	57.74	53.87	56.30	102.74	135.81	79.20	91.11	34.53
Inventory Days	109.25	77.67	46.15	55.54	181.31	832.82	81.53	46.98	197.71	0.00
Days Payable	45.42	43.12	41.39	49.24	63.34	436.97	41.89	28.91	342.19
Cash Conversion Cycle	117.30	92.30	58.62	62.60	220.71	531.66	118.84	109.18	-109.95
Working Capital Days	47.76	24.71	-6.46	-29.53	-139.69	-317.99	-72.00	-66.89	-764.53
ROCE %	4.29%	3.39%	2.84%	2.00%	1.98%	0.59%	-40.35%	-23.83%	-10.95%	5.90%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoters	28.24%	28.24%	28.24%	28.24%	29.61%	29.61%	29.61%	29.61%	29.61%	29.61%	29.61%	25.85%
Public	71.77%	71.77%	71.76%	71.75%	70.40%	70.39%	70.39%	70.39%	70.39%	70.39%	70.38%	74.15%
No. of Shareholders	18,670	18,661	18,638	18,628	18,595	18,584	18,536	18,509	18,514	18,481	18,488	18,468

Shareholding Pattern Chart

No. of Shareholders

Adline Chem Lab Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	-0.21	-0.25	-7.24	1.23	-2.19
Diluted EPS (Rs.)	-0.21	-0.25	-7.24	1.23	-2.19
Cash EPS (Rs.)	-0.22	-0.25	-7.09	1.83	-0.44
Book Value[Excl.RevalReserv]/Share (Rs.)	-2.55	-2.93	-2.68	4.53	3.30
Book Value[Incl.RevalReserv]/Share (Rs.)	-2.55	-2.93	-2.68	4.53	3.30
Revenue From Operations / Share (Rs.)	0.00	0.00	0.00	1.26	10.82
PBDIT / Share (Rs.)	-0.07	-0.24	0.33	-0.19	-0.38
PBIT / Share (Rs.)	-0.07	-0.24	0.18	-0.78	-2.14
PBT / Share (Rs.)	-0.35	-0.24	-7.24	1.15	-2.19
Net Profit / Share (Rs.)	-0.22	-0.25	-7.24	1.23	-2.19
PBDIT Margin (%)	0.00	0.00	0.00	-15.18	-3.60
PBIT Margin (%)	0.00	0.00	0.00	-62.71	-19.77
PBT Margin (%)	0.00	0.00	0.00	91.22	-20.28
Net Profit Margin (%)	0.00	0.00	0.00	97.44	-20.28
Return on Networth / Equity (%)	0.00	0.00	0.00	27.10	-66.47
Return on Capital Employeed (%)	-74.83	10.03	-8.69	-15.66	-53.59
Return On Assets (%)	-175.09	-347.38	-6858.26	14.72	-22.77
Long Term Debt / Equity (X)	-0.99	0.00	0.00	0.00	0.00
Total Debt / Equity (X)	-0.99	-0.86	-0.85	0.49	1.30
Asset Turnover Ratio (%)	0.00	0.00	0.00	0.14	0.95
Current Ratio (X)	4.46	0.02	0.04	0.22	0.60
Quick Ratio (X)	4.46	0.02	0.04	0.09	0.48
Interest Coverage Ratio (X)	-0.27	0.00	0.00	-15.19	-6.97
Interest Coverage Ratio (Post Tax) (X)	0.17	0.00	0.00	-56.48	-38.25
Enterprise Value (Cr.)	9.18	18.23	4.43	5.11	5.64
EV / Net Operating Revenue (X)	0.00	0.00	0.00	6.93	0.89
EV / EBITDA (X)	-204.49	-124.95	22.32	-45.65	-24.76
MarketCap / Net Operating Revenue (X)	0.00	0.00	0.00	5.21	0.47
Price / BV (X)	-5.20	-9.80	-2.02	1.45	1.55
Price / Net Operating Revenue (X)	0.00	0.00	0.00	5.21	0.47
EarningsYield	-0.01	-0.01	-1.34	0.18	-0.43

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Adline Chem Lab Ltd. is a Public Limited Listed company incorporated on 06/07/1988 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24231GJ1988PLC010956 and registration number is 010956. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 0.00 Cr. and Equity Capital is Rs. 5.85 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Pharmaceuticals	403, Sarthik II, Opp. Rajpath Club, Ahmedabad Gujarat 380054	Contact not found

Management
Name	Position Held
Mr. Sarang Bharatbhai Pathak	Managing Director
Mr. Hemant Amrish Parikh	Director
Mr. Dhawal Akhilesh Deopura	Director
Ms. Shivani Pathak	Director
Mr. Vrushank Balkrushna Patel	Additional Director
Mr. Nilay Jitendrabhai Vaghasiya	Additional Director

FAQ

What is the intrinsic value of Adline Chem Lab Ltd and is it undervalued?

As of 03 May 2026, Adline Chem Lab Ltd's intrinsic value is ₹18.86, which is 66.90% higher than the current market price of ₹11.30, suggesting the stock is undervalued. This is calculated using the PE ratio method factoring in ROE (%), book value (₹2.75), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Adline Chem Lab Ltd?

Adline Chem Lab Ltd is trading at ₹11.30 as of 03 May 2026, with a FY2026-2027 high of ₹19.1 and low of ₹7.60. The stock is currently in the middle of its 52-week range. Market cap stands at ₹6.60 Cr..

How does Adline Chem Lab Ltd's P/E ratio compare to its industry?

Adline Chem Lab Ltd has a P/E ratio of 220, which is above the industry average of 59.48. This significantly elevated P/E suggests the market expects strong future growth, or the stock may be overpriced relative to current earnings.

Is Adline Chem Lab Ltd financially healthy?

Key indicators for Adline Chem Lab Ltd: ROCE of % is on the lower side compared to the industry average of 16.35%; ROE of % is below ideal levels (industry average: 15.16%). Dividend yield is 0.00 %.

Is Adline Chem Lab Ltd profitable and how is the profit trend?

Adline Chem Lab Ltd reported a net profit of ₹0 Cr in Mar 2025. Compared to ₹1 Cr in Mar 2022, the net profit shows a declining trend.

Does Adline Chem Lab Ltd pay dividends?

Adline Chem Lab Ltd has a dividend yield of 0.00 % at the current price of ₹11.30. The company is currently not paying meaningful dividends.